Novel Coronavirus (SARS-CoV-2/COVID-19)
This is a list of resources on supplies and personal protective equipment (PPE) while treating the novel coronavirus COVID-19 pandemic.
A recent report, “Journey Toward the Next Normal,” from the Providence Digital Innovation Group provides some answers and examines the role that technology and digital health will play in achieving this transformation.
AHA’s The Value Initiative is providing new resources to support hospitals’ and health systems’ efforts to adopt team-based care for patients with an acute or chronic illness.
A Lancet study published Sept. 25 indicates that few in the U.S. adult population formed antibodies against SARS-CoV-2, at least during the virus’ first wave in this country.
The Centers for Medicare & Medicaid Services released a guide to help laboratories apply for Clinical Laboratory Improvement Amendments certification, which includes information on the expedited review process implemented for the COVID-19 public health emergency.
States and COVID-19 testing laboratories have reported more than 277,000 COVID-19 cases in school-aged children since March, with about twice as many cases in children aged 12-17 than younger children, the Centers for Disease Control and Prevention reported.
The COVID-19 pandemic has brought increased attention to the issue of health care disparities. And it’s clear we’ve got a lot of work ahead of us to close the gaps.
As hospitals and health systems across the country begin and continue the “recovery” process during the COVID-19 outbreak, the AHA is keeping you updated with the latest information and resources. An important area to address is the role of governing boards as hospitals and health systems resume…
This podcast highlights issues such as: prospective board authorizations for emergency spending and policy modifications; logistics for emergency board meetings and decision making; how boards can support and equally importantly not be a burden to management; clarifying emergency authority between…
The AHA today urged the Department of Health and Human Services to reinstate the COVID-19 Provider Relief Fund reporting requirements outlined in its June 19 frequently asked question that defined both expenses and lost revenues attributable to COVID-19.